Share on

Global RNA Analysis Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By End User, Type, Application & Region – Industry Forecasts (2022 to 2027)

Published: January, 2022
ID: 4383
Pages: 178
Formats: report pdf report excel report power bi report ppt

RNA Analysis Market Size (2022 to 2027)

The global RNA analysis market size is forecasted to be worth USD 5.35 billion by 2027 from USD 2.79 billion in 2022, growing at a CAGR of 13.9% from 2022 to 2027.

Transcriptomics/RNA analysis is the study of the transcriptome, or the entire collection of RNA transcripts generated by the genome, under specific conditions, in a given environment, or a given cell, utilizing high-throughput technologies like microarray analysis. To gain a comprehensive understanding of the market, the report's analysts conducted primary and secondary research. The data is presented both descriptively and metaphorically. Interviews, seminars, podcasts, national and international RNS-seq sites, and other comparable sources were used to compile the data. RNA sequencing (RNAseq) is a widely used method for determining gene expression levels. It's a flexible approach for detecting and characterizing gene expression, mutations, gene fusions, and noncoding RNAs, among other things.

Targeted RNA sequencing is a precise approach for identifying and sequencing individual transcripts of interest, providing quantitative and qualitative data. The paper's authors used primary and secondary research, which included information gathered from various producers and experts. Authors have also concluded that Porter's five force model may assist in making a profit in the sector and taking critical business initiatives to outperform competitors. In a single amplification procedure, targeted RNA sequencing permits measurement of messenger RNA (mRNA) or targeted noncoding RNA (ncRNA) levels for up to 300 customer-defined genes. Next-generation sequencing techniques have been transformed by the ability to target a specific region of the genome. Exome analysis has proliferated, with bespoke panels for exome-style pull-down being utilized to evaluate thousands of samples significantly and amplicon analysis, allowing these samples to be run in a single experiment.


The global RNA Sequencing analysis market is expected to be driven by the increasing need for personalized medicine and the burgeoning uses of RNA sequencing in the transcriptomics industry.

Also, the market is predicted to develop due to the rising demand for customized treatment and RNA sequencing uses in transcriptomics. Due to the rapid improvements in the transcriptomics sector, the RNA analysis/transcriptomics market is expected to increase significantly throughout the forecast period. The growing focus on biomarker development and toxicogenomic and the growing interest in outsourcing services are likely to provide substantial potential prospects for the global RNA analysis/transcriptomics market participants.

The remarkable increase in both private and non-private investments may create amazing potential for the RNA analysis/transcriptomics market over the forecast period. The growing interest in outsourcing services and the increased focus on biomarker discovery and toxicogenomic are likely to provide considerable growth possibilities for worldwide market participants. The rising rates of genetic mutations in genetic variants and carcinogens are enticing the RNA analysis/transcriptomics market to expand rapidly. Moreover, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics are most likely to encourage market growth.


On the other hand, the high capital investment requirements and data management concerns are projected to limit this market's growth to some extent. High research investment, high failure rates, and challenges with medication delivery are all problems limiting the market's growth for firms working in this industry. RNA-based therapeutics have the potential to flourish despite the limitations, owing to the biotechnology and pharmaceutical sectors' growing interest.

Impact of COVID-19 on the global RNA Analysis market:

Due to attempts to better understand the mechanics of the virus, the COVID-19 epidemic has stimulated scientific activities. We predict that the use of transcriptome technologies and customized medicine will expand at a steady rate over the next five years. Because of the increased research activity, both the availability of research money and the demand for high-throughput technology are expected to expand. With an unprecedented demand for the study and treatment of COVID-19, SARS-CoV-2 has brought the RNA sequencing business to the center of attention. The demand for the healthcare system is increasing as the number of instances of COVID-19 rises dramatically over the world. To decipher the genetic information of SARS-CoV-2, clinicians and scientists are utilizing RNA sequencing in large numbers.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By End User, Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa


This research report on the global RNA analysis market has been segmented and sub-segmented into the following categories.

RNA Analysis Market - By End User:

  • Academic Research & Government Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centres

Based on the End User, the Pharmaceutical and Biotechnology companies are expected to register a significant share in the global market during the forecast period, followed by the hospitals and diagnostics centers due to the mounting diseases and demand for the drugs. Academic researchers and government institutes are using this technology to fulfill the demand. The rising prevalence of DNA& RNA technologies will keep this segment at a high pace. 

RNA Analysis Market - By Type:

  • Microarrays
    • Reagents
    • Instruments
    • Software
  • Polymerase Chain Reaction (PCR)
  • Sequencing Technologies
  • RNAi Gene Silencing

Based on the type, the microarray segment holds the largest market share as it is used to find out the diseases related to genes. The rising chronic diseases and inborn genetic diseases are the reasons for the growth of these segments. Microarray instrument’s demand is increasing because of the rising advances of the technologies of drug manufacturing. Also, the demand is rising for customized medicine is expected to raise the market share of microarray instruments. The microarray software segment is growing at a higher pace because of the rising advancements in software developments. 

RNA Analysis Market - By Application:

  • Clinical Diagnosis
  • Drug Discovery
  • Toxic genomics

Based on the application, the Drug discovery application holds the major share in the market, followed by toxic genomics because of the rising population and diseases. Also, the improvement in laboratory practices. Clinical diagnosis is expected to rise in the forecast period due to the rise in research on microorganisms and the antibody’s information collection. Also, the activities related to genes and proteins are expected to rise in the future. 

RNA Analysis Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

The market is covered by Europe, North America, Latin America, the Middle East, and Africa. The major market is captured by North America, followed by Europe Increasing support by the governments and increasing awareness of the particular products are prominent factors for the market growth in these countries. Rising incidences of chronic diseases are also greatly influencing the demand of the market. 

Asia Pacific region is expected to have higher growth in the forecast period due to increased spending from major countries like India and China for RNA sequencing on research and development.   


Some of the notable companies operating in the global RNA analysis market profiled in the report are Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.) and Thermofisher Scientific Inc. (U.S.).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample